Brookstone Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$431K Sell
5,515
-133
-2% -$10.4K 0.01% 785
2025
Q1
$409K Buy
5,648
+164
+3% +$11.9K 0.01% 758
2024
Q4
$406K Buy
5,484
+616
+13% +$45.6K 0.01% 749
2024
Q3
$321K Sell
4,868
-2,414
-33% -$159K ﹤0.01% 818
2024
Q2
$636K Sell
7,282
-4,993
-41% -$436K 0.01% 590
2024
Q1
$1.17M Buy
12,275
+383
+3% +$36.6K 0.02% 452
2023
Q4
$907K Buy
11,892
+892
+8% +$68K 0.02% 482
2023
Q3
$760K Sell
11,000
-3,748
-25% -$259K 0.02% 485
2023
Q2
$1.33M Buy
14,748
+6,668
+83% +$602K 0.03% 382
2023
Q1
$679K Buy
8,080
+1,676
+26% +$141K 0.01% 527
2022
Q4
$493K Buy
6,404
+269
+4% +$20.7K 0.01% 580
2022
Q3
$507K Buy
6,135
+141
+2% +$11.7K 0.01% 560
2022
Q2
$590K Buy
5,994
+223
+4% +$22K 0.01% 533
2022
Q1
$701K Buy
+5,771
New +$701K 0.01% 481
2021
Q2
Sell
-6,729
Closed -$563K 718
2021
Q1
$563K Buy
6,729
+164
+2% +$13.7K 0.02% 337
2020
Q4
$599K Buy
6,565
+115
+2% +$10.5K 0.02% 304
2020
Q3
$515K Sell
6,450
-628
-9% -$50.1K 0.02% 268
2020
Q2
$489K Sell
7,078
-692
-9% -$47.8K 0.03% 241
2020
Q1
$489K Sell
7,770
-261
-3% -$16.4K 0.03% 212
2019
Q4
$625K Sell
8,031
-324
-4% -$25.2K 0.03% 252
2019
Q3
$612K Sell
8,355
-1,035
-11% -$75.8K 0.03% 237
2019
Q2
$578K Buy
9,390
+1,014
+12% +$62.4K 0.03% 227
2019
Q1
$534K Buy
8,376
+939
+13% +$59.9K 0.03% 201
2018
Q4
$380K Sell
7,437
-378
-5% -$19.3K 0.03% 197
2018
Q3
$454K Buy
7,815
+1,623
+26% +$94.3K 0.03% 287
2018
Q2
$300K Sell
6,192
-1,566
-20% -$75.9K 0.03% 299
2018
Q1
$361K Buy
+7,758
New +$361K 0.03% 250
2015
Q4
Sell
-222
Closed -$5K 378
2015
Q3
$5K Hold
222
﹤0.01% 1396
2015
Q2
$5K Buy
+222
New +$5K ﹤0.01% 1480